Local and Systemic Administration of Mesenchymal Stem Cells in Regeneration of Mandibular Defects: An Experimental Study
Journal of "Regeneration, Reconstruction & Restoration" (Triple R),
Vol. 5 (2020),
24 March 2020
,
Page e10
https://doi.org/10.22037/rrr.v5i1.30375
Abstract
Introduction: Mesenchymal stem cells (MSCs) have been utilized as an aid in regeneration of bone defects however due to the poor homing ability via systemic injection, local administration, genetic manipulation has been used more. The present study aimed to compare the local and systemic application of MSCs in regeneration of bone defects.
Materials and Methods: Sixty Wistar male rats were used in this study. Circular 5×5 mm bone defects were created in the angle of the mandible. Autogenous bone marrow mesenchymal stem cells (BMMSCs) were obtained and culture expanded. Green fluorescent positive (GFP+) transfection has been performed for the possible detection of the cells in the healed bone. The rats were randomly treated in four groups; 1. Beta tricalcium phosphate (β-TCP) scaffold seeded with MSC (β-TCP+MSC), 2. Intravenous MSC injection with β-TCP scaffold in the defect (MSC), 3. β-TCP without cell therapy (β-TCP) and 4. Control defects that left empty. The rats were euthanized after 8 weeks. New bone formation (BF) were investigated by hematoxylin and eosin staining.
Results: Localized cell therapy (β-TCP+MSC group) showed the highest healing rate (BF= 54.05±2.39%) followed by MSC systemic injection (BF= 22.69±3.87%) (P≤0.05). Inflammatory cells infiltration was evident dominantly in systemic injection cell group. Immunohistchemical analysis showed existence of the MSCs around the defects. GFP+ cells were mainly detected in the defect in β-TCP+MSC group while few GFP+ cells were detected in the MSC systemic group.
Conclusion: local application of the MSCs with synthetic scaffold showed better results than intravenous administration of MSCs in treatment of rat mandible bone defects.
- Mesenchymal stem cells
- Bone regeneration
- Regenerative medicine
- Tissue Engineering
How to Cite
References
Hosseini FS, Soleimanifar F, Ardeshirylajimi A, et al. In vitro osteogenic differentiation of stem cells with different sources on composite scaffold containing natural bioceramic and polycaprolactone. Artif Cells Nanomed Biotechnol. 2019;47(1):300-307.
Merkx M, Fennis J, Verhagen C, Stoelinga P. Reconstruction of the mandible using preshaped 2.3 mm titanium plates, autogenous particulate cortico-cancellous bone grafts and platelet rich plasma: a report on eight patients. J International journal of oral & maxillofacial surgery. 2004;33(8):733-739.
Fennis J, Stoelinga P, Jansen J. Reconstruction of the mandible with an autogenous irradiated cortical scaffold, autogenous corticocancellous bone-graft and autogenous platelet-rich-plasma: an animal experiment. J International journal of oral & maxillofacial surgery. 2005;34(2):158-166.
Khojasteh A, Hosseinpour S. Challenges in the Rehabilitation Handling of Large and Localized Oral and Maxillofacial Defects. In: Applications of Biomedical Engineering in Dentistry. Springer; 2020:239-262.
Eufinger H, Leppänen H. Iliac crest donor site morbidity following open and closed methods of bone harvest for alveolar cleft osteoplasty. Journal of Cranio-Maxillofacial Surgery. 2000;28(1):31-38.
Behnia H, Khojasteh A, Soleimani M, et al. Secondary repair of alveolar clefts using human mesenchymal stem cells. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics. 2009;108(2):e1-6.
Nkenke E, Schultze‐Mosgau S, Kloss F, Neukam F, Radespiel‐Tröger M. Morbidity of harvesting of chin grafts: a prospective study. Clinical Oral Implants Research. 2001;12(5):495-502.
Friedlaender GE. Immune Responses to Osteochondral Allografts Current Knowledge and Future Directions. Clinical orthopaedics and related research. 1983;174:58-68.
Jackson DW, Grood ES, Goldstein JD, et al. A comparison of patellar tendon autograft and allograft used for anterior cruciate ligament reconstruction in the goat model. The American Journal of Sports Medicine. 1993;21(2):176-185.
Zuk PA, Zhu M, Ashjian P, et al. Human adipose tissue is a source of multipotent stem cells. J Molecular biology of the cell. 2002;13(12):4279-4295.
Kern S, Eichler H, Stoeve J, Klüter H, Bieback K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. J Stem cells. 2006;24(5):1294-1301.
Lee OK, Kuo TK, Chen W-M, Lee K-D, Hsieh S-L, Chen T-H. Isolation of multipotent mesenchymal stem cells from umbilical cord blood. J Blood. 2004;103(5):1669-1675.
Warnke P, Springer I, Wiltfang J, et al. Growth and transplantation of a custom vascularised bone graft in a man. J The Lancet. 2004;364(9436):766-770.
Kaigler D, Pagni G, Park CH, et al. Stem cell therapy for craniofacial bone regeneration: a randomized, controlled feasibility trial. J Cell transplantation. 2013;22(5):767-777.
Friedenstein A, Chailakhjan R, Lalykina K. The development of fibroblast colonies in monolayer cultures of guinea‐pig bone marrow and spleen cells. J Cell Proliferation. 1970;3(4):393-403.
Khojasteh A, Behnia H, Dashti SG, Stevens M. Current trends in mesenchymal stem cell application in bone augmentation: a review of the literature. J Oral Maxillofac Surg. 2012;70(4):972-982.
Khojasteh A, Motamedian SR. Mesenchymal stem cell therapy for treatment of craniofacial bone defects: 10 years of experience. J Regeneration, Reconstruction & Restoration. 2016;1(1):1.
Khojasteh A, Dashti SG, Dehghan MM, Behnia H, Abbasnia P, Morad G. The osteoregenerative effects of platelet-derived growth factor BB cotransplanted with mesenchymal stem cells, loaded on freeze-dried mineral bone block: a pilot study in dog mandible. J Biomed Mater Res B Appl Biomater. 2014;102(8):1771-1778.
Du J, Shan Z, Ma P, Wang S, Fan Z. Allogeneic bone marrow mesenchymal stem cell transplantation for periodontal regeneration. Journal of dental research. 2014;93(2):183-188.
Motamedian SR, Hosseinpour S, Ahsaie MG, Khojasteh A. Smart scaffolds in bone tissue engineering: A systematic review of literature. World J Stem Cells. 2015;7(3):657-668.
Gibon E, Lu L, Goodman SB. Aging, inflammation, stem cells, and bone healing. J Stem cell research & therapy. 2016;7(1):44.
Kumagai K, Vasanji A, Drazba JA, Butler RS, Muschler GF. Circulating cells with osteogenic potential are physiologically mobilized into the fracture healing site in the parabiotic mice model. Journal of Orthopaedic Research. 2008;26(2):165-175.
Horwitz EM, Gordon PL, Koo WK, et al. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. J Proceedings of the National Academy of Sciences. 2002;99(13):8932-8937.
Li Y, Chen J, Zhang CL, et al. Gliosis and brain remodeling after treatment of stroke in rats with marrow stromal cells. Glia. 2005;49(3):407-417.
Wilson SM, Goldwasser MS, Clark SG, et al. Adipose-derived mesenchymal stem cells enhance healing of mandibular defects in the ramus of swine. Journal of Oral and Maxillofacial Surgery. 2012;70(3):e193-e203.
Barbash IM, Chouraqui P, Baron J, et al. Systemic delivery of bone marrow–derived mesenchymal stem cells to the infarcted myocardium feasibility, cell migration, and body distribution. Circulation. 2003;108(7):863-868.
Khojasteh A, Behnia H, Hosseini FS, Dehghan MM, Abbasnia P, Abbas FM. The effect of PCL-TCP scaffold loaded with mesenchymal stem cells on vertical bone augmentation in dog mandible: a preliminary report. Journal of biomedical materials research Part B, Applied biomaterials. 2013;101(5):848-854.
Shayesteh YS, Khojasteh A, Soleimani M, Alikhasi M, Khoshzaban A, Ahmadbeigi N. Sinus augmentation using human mesenchymal stem cells loaded into a beta-tricalcium phosphate/hydroxyapatite scaffold. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics. 2008;106(2):203-209.
Huang S, Xu L, Zhang Y, Sun Y, Li G. Systemic and local administration of allogeneic bone marrow derived mesenchymal stem cells promotes fracture healing in rats. Cell transplantation. 2015.
Ocarino NdM, Boeloni JN, Jorgetti V, Gomes DA, Goes AM, Serakides R. Intra-bone marrow injection of mesenchymal stem cells improves the femur bone mass of osteoporotic female rats. Connective tissue research. 2010;51(6):426-433.
Gasser J. Stem cells in the treatment of osteoporosis. European Cells and Materials. 2003;6(2):21.
Kanazawa M, Atsuta I, Ayukawa Y, et al. The influence of systemically or locally administered mesenchymal stem cells on tissue repair in a rat oral implantation model. Int J Implant Dent. 2018;4(1):2.
Liu Y, Wang L, Kikuiri T, et al. Mesenchymal stem cell-based tissue regeneration is governed by recipient T lymphocytes via IFN-[gamma] and TNF-[alpha]. Nature medicine. 2011;17(12):1594-1601.
Moshaverinia A, Chen C, Xu X, et al. Regulation of the Stem Cell–Host Immune System Interplay Using Hydrogel Coencapsulation System with an Anti‐Inflammatory Drug. Advanced Functional Materials. 2015;25(15):2296-2307.
Du J, Shan Z, Ma P, Wang S, Fan Z. Allogeneic bone marrow mesenchymal stem cell transplantation for periodontal regeneration. Journal of dental research. 2014;93(2):183-188.
Zhang Y, Xiong Y, Chen X, Chen C, Zhu Z, Li L. Therapeutic effect of bone marrow mesenchymal stem cells pretreated with acetylsalicylic acid on experimental periodontitis in rats. J International immunopharmacology. 2018;54:320-328.
Liu Y, Yang R, Shi S. Systemic infusion of mesenchymal stem cells improves cell-based bone regeneration via upregulation of regulatory T cells. Tissue Engineering Part A. 2015;21(3-4):498-509.
- Abstract Viewed: 163 times
- PDF Downloaded: 86 times